Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Cited by (1,077)

Items 301–400 of 1,077

1. Prediction of ‘drug-likeness’
   W. Patrick Walters, Mark A. Murcko · 2002 · Advanced Drug Delivery Reviews
2. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery – An update
   Scott V. Jermain, Chris Brough, Robert O. Williams · 2017 · International Journal of Pharmaceutics
3. Impact of solid state properties on developability assessment of drug candidates
   Lian Huang · 2004 · Advanced Drug Delivery Reviews
4. Fsp3: A new parameter for drug-likeness
   Wenxiu Wei, Srinivasulu Cherukupalli, Lanlan Jing, Xinyong Liu, Peng Zhan · 2020 · Drug Discovery Today
5. Recognizing Pitfalls in Virtual Screening: A Critical Review
   Scior, Thomas, Bender, Andreas, Tresadern, Gary, Medina-Franco, José L., Martínez-Mayorga, Karina, Langer, Thierry, Cuanalo-Contreras, Karina, Agrafiotis, Dimitris K. · 2012 · Journal of Chemical Information and Modeling
6. The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time
   Peter Ertl, Eva Altmann, Jeffrey M. McKenna · 2020 · Journal of Medicinal Chemistry
7. Molecular photoswitches in aqueous environments
   Jana Volarić, Wiktor Szymański, Nadja A. Simeth, Ben L. Feringa · 2021 · Chemical Society Reviews
8. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption
   Joseph M. Custodio, Chi‐Yuan Wu, Leslie Z. Benet · 2007 · Advanced Drug Delivery Reviews
9. Computational design of molecules for an all-quinone redox flow battery
   Süleyman Er, Changwon Suh, Michael P. Marshak, Alán Aspuru‐Guzik · 2014 · Chemical Science
10. 50 years of oral lipid-based formulations: provenance, progress and future perspectives
    Feeney, Orlagh M., Crum, Matthew F., McEvoy, Claire L., Trevaskis, Natalie L., Williams, Hywel D., Pouton, Colin W., Charman, William N., Bergström, Christel A.S., Porter, Christopher J.H. · 2016 · Advanced Drug Delivery Reviews
11. Fragment-Based Lead Discovery Using X-ray Crystallography
    Michael J. Hartshorn, Christopher W. Murray, Anne Cleasby, Martyn Frederickson, Ian J. Tickle, Harren Jhoti · 2004 · Journal of Medicinal Chemistry
12. Current strategies for the design of PROTAC linkers: a critical review
    Troup, Robert I., Fallan, Charlene, Baud, Matthias G. J. · 2020 · Exploration of Targeted Anti-tumor Therapy
13. Proteolysis targeting chimeras (PROTACs) in ‘beyond rule-of-five’ chemical space: Recent progress and future challenges
    Edmondson, Scott D., Yang, Bin, Fallan, Charlene · 2019 · Bioorganic & Medicinal Chemistry Letters
14. An Aggregation Advisor for Ligand Discovery
    John J. Irwin, Da Duan, Hayarpi Torosyan, Allison K. Doak, Kristin T. Ziebart, Teague Sterling, Gurgen Tumanian, Brian K. Shoichet · 2015 · Journal of Medicinal Chemistry
15. Drug discovery beyond the ‘rule-of-five’
    Ming‐Qiang Zhang, Barrie M. Wilkinson · 2007 · Current Opinion in Biotechnology
16. Plant derived substances with anti-cancer activity: from folklore to practice
    Marcelo Fridlender, Yoram Kapulnik, Hinanit Koltai · 2015 · Frontiers in Plant Science
17. Target validation using chemical probes
    Mark E. Bunnage, Eugene L. Piatnitski Chekler, Lyn H. Jones · 2013 · Nature Chemical Biology
18. Constraining Cyclic Peptides To Mimic Protein Structure Motifs
    Timothy A. Hill, Nicholas E. Shepherd, Frederik Diness, David P. Fairlie · 2014 · Angewandte Chemie International Edition
19. Perspectives on NMR in drug discovery: a technique comes of age
    Maurizio Pellecchia, Ivano Bertini, David Cowburn, Claudio Dalvit, Ernest Giralt, Wolfgang Jahnke, Thomas Leroy James, Steve W. Homans, Horst Kessler, Claudio Luchinat et al. · 2008 · Nature Reviews Drug Discovery
20. Virtual Screening for Potential Inhibitors of Human Hexokinase II for the Development of Anti-Dengue Therapeutics
    Suriyea Tanbin, Fazia Adyani Ahmad Fuad, Azzmer Azzar Abdul Hamid · 2020 · BioTech
21. Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides
    Taha Rezai, Jonathan E. Bock, Mai V. Zhou, Chakrapani Kalyanaraman, R. Scott Lokey, Matthew P. Jacobson · 2006 · Journal of the American Chemical Society
22. Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor
    Robert Jr. Roskoski · 2007 · Biochemical and Biophysical Research Communications
23. Bioavailability of phytochemicals and its enhancement by drug delivery systems
    Farrukh Aqil, Radha Munagala, Jeyaprakash Jeyabalan, Manicka V. Vadhanam · 2013 · Cancer Letters
24. Metal based drugs: from serendipity to design
    Simon Paul Fricker · 2007 · Dalton Transactions
25. Finding the sweet spot: the role of nature and nurture in medicinal chemistry
    Michael M. Hann, György Miklós Keserű · 2012 · Nature Reviews Drug Discovery
26. High throughput solubility measurement in drug discovery and development
    Jochem Alsenz, Manfred Kansy · 2007 · Advanced Drug Delivery Reviews
27. Pybel: a Python wrapper for the OpenBabel cheminformatics toolkit
    Noel M. O’Boyle, Chris Morley, Geoffrey Hutchison · 2008 · Chemistry Central Journal
28. Direct Trifluoromethylthiolation Reactions: The “Renaissance” of an Old Concept
    Fabien Toulgoat, Sébastien Alazet, Thierry Billard · 2014 · European Journal of Organic Chemistry
29. Antidiabetic Activities of Triterpenoids Isolated from Bitter Melon Associated with Activation of the AMPK Pathway
    Min-Jia Tan, Ji-Ming Ye, Nigel A. Turner, Cordula Hohnen-Behrens, Chang‐Qiang Ke, Chunping Tang, Tong Chen, Hans‐Christoph Weiß, Ernst-Rudolf Gesing, Alex Rowland et al. · 2008 · Chemistry & Biology
30. IMPPAT 2.0: An Enhanced and Expanded Phytochemical Atlas of Indian Medicinal Plants
    R.P. Vivek-Ananth, Karthikeyan Mohanraj, Ajaya Kumar Sahoo, Areejit Samal · 2023 · ACS Omega
31. Molecular modeling in drug discovery
    Temitope Isaac Adelusi, Abdul-Quddus Kehinde Oyedele, Ibrahim Damilare Boyenle, Abdeen Tunde Ogunlana, Rofiat Oluwabusola Adeyemi, Ukachi Chiamaka Divine, Mukhtar Oluwaseun Idris, Olamide Tosin Olaoba, Ibrahim Olaide Adedotun, Elijah Kolawole Oladipo et al. · 2022 · Informatics in Medicine Unlocked
32. Advances in Targeting ‘Undruggable’ transcription Factors With Small Molecules
    Henley, Madeleine J., Koehler, Angela N. · 2021 · Nature Reviews Drug Discovery
33. Salmonellosis: An Overview of Epidemiology, Pathogenesis, and Innovative Approaches to Mitigate the Antimicrobial Resistant Infections
    Bibek Lamichhane, Asmaa M. M. Mawad, Mohammed A. Saleh, William G. Kelley, Patrick J. Harrington, Cayenne W. Lovestad, Jessica Amezcua, Mohamed M. Sarhan, Mohamed Ezzat El Zowalaty, Hazem H. Ramadan et al. · 2024 · Antibiotics
34. Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology
    Jiangyong Gu, Yuanshen Gui, Lirong Chen, Gu Yuan, Huizhe Lu, Xiaojie Xu · 2013 · PLoS ONE
35. Ethnobotany and the Role of Plant Natural Products in Antibiotic Drug Discovery
    Gina Porras, François Chassagne, James T. Lyles, Lewis Marquez, Micah Dettweiler, Akram M. Salam, Tharanga Samarakoon, Sarah Shabih, Darya Raschid Farrokhi, Cassandra Leah Quave · 2020 · Chemical Reviews
36. Saxitoxin, a toxic marine natural product that targets a multitude of receptors
    Lyndon E Llewellyn · 2006 · Natural Product Reports
37. Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
    Robert Jr. Roskoski · 2024 · Pharmacological Research
38. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
    Zehra Edis, Junli Wang, Muhammad Khurram Waqas, Munazza Ijaz, Munazza Ijaz · 2021 · International Journal of Nanomedicine
39. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
    Peng Wang, Juan Carlos Álvarez-Pérez, Dan P. Felsenfeld, Hongtao Liu, Sharmila Sivendran, Aaron S. Bender, Anil Kumar, Roberto Sánchez, Donald K. Scott, Adolfo Garcı́a-Ocaña et al. · 2015 · Nature Medicine
40. Approaches to Measure Chemical Similarity – a Review
    Nina Nikolova, Joanna S. Jaworska · 2003 · QSAR & Combinatorial Science
41. Physical chemistry of supersaturated solutions and implications for oral absorption
    Lynne S. Taylor, Geoff G. Z. Zhang · 2016 · Advanced Drug Delivery Reviews
42. A de novo molecular generation method using latent vector based generative adversarial network
    Oleksii Prykhodko, Simon Johansson, Panagiotis-Christos Kotsias, Josep Arús‐Pous, Esben Jannik Bjerrum, Ola Engkvist, Hongming Chen · 2019 · Journal of Cheminformatics
43. Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems
    Shweta Kirti Gupta, Rajesh Kesarla, Abdelwahab Omri · 2013 · ISRN Pharmaceutics
44. Chemical substructures that enrich for biological activity
    Klekota, Justin, Roth, Frederick P. · 2008 · Bioinformatics
45. Selective Chemical Inhibition of agr Quorum Sensing in Staphylococcus aureus Promotes Host Defense with Minimal Impact on Resistance
    Erin K. Sully, Natalia Małachowa, Bradley O. Elmore, Susan M. Alexander, Jon Femling, Brian M. Gray, Frank R. DeLeo, Michael J. Otto, Ambrose L. Cheung, Bruce S. Edwards et al. · 2014 · PLoS Pathogens
46. Constrained Bayesian optimization for automatic chemical design using variational autoencoders
    Ryan‐Rhys Griffiths, José Miguel Hernández-Lobato · 2019 · Chemical Science
47. New approaches to molecular cancer therapeutics
    Ian Collins, Paul Workman · 2006 · Nature Chemical Biology
48. Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
    Frank M. Boeckler, Andreas C. Joerger, Gaurav Jaggi, Trevor J. Rutherford, Dmitry B. Veprintsev, Alan Roy Fersht · 2008 · Proceedings of the National Academy of Sciences
49. Intestinal permeation enhancers for oral peptide delivery
    Sam Maher, Randall J. Mrsny, David J. Brayden · 2016 · Advanced Drug Delivery Reviews
50. Recent progress in targeted delivery vectors based on biomimetic nanoparticles
    Li Chen, Weiqi Hong, Wenyan Ren, Ting Xu, Zhiyong Qian, Zhiyao He · 2021 · Signal Transduction and Targeted Therapy
51. Application and Limitations of X‐ray Crystallographic Data in Structure‐Based Ligand and Drug Design
    A. M. Davis, Simon J. Teague, Gerard J. Kleywegt · 2003 · Angewandte Chemie International Edition
52. Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
    Yangbo Feng, Philip V. LoGrasso, Olivier Defert, Rongshi Li · 2015 · Journal of Medicinal Chemistry
53. Reinvent 4: Modern AI–driven generative molecule design
    Hannes H. Loeffler, Jiazhen He, Alessandro Tibo, Jon Paul Janet, Alexey Voronov, Lewis Mervin, Ola Engkvist · 2024 · Journal of Cheminformatics
54. Synthesis and Structure−Activity Relationship Study of Potent Trypanocidal Thio Semicarbazone Inhibitors of the Trypanosomal Cysteine Protease Cruzain
    Xiaohui Du, Chun Guo, Elizabeth J. Hansell, Patricia S. Doyle, Conor R. Caffrey, Tod P. Holler, James Hobson McKerrow, Fred E. Cohen · 2002 · Journal of Medicinal Chemistry
55. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea
    Chung Shu Yang, Jinsong Zhang, Le Zhang, Jinbao Huang, Yijun Wang · 2015 · Molecular Nutrition & Food Research
56. Role of Polyphenols and Other Phytochemicals on Molecular Signaling
    Swapna Upadhyay, Madhulika Dixit · 2015 · Oxidative Medicine and Cellular Longevity
57. Nonleadlikeness and leadlikeness in biochemical screening
    Gilbert M. Rishton · 2003 · Drug Discovery Today
58. Comprehensive prediction of secondary metabolite structure and biological activity from microbial genome sequences
    Michael A. Skinnider, Chad W. Johnston, Mathusan Gunabalasingam, Nishanth J. Merwin, Agata Kieliszek, Robyn J. MacLellan, Haoxin Li, Michael R. M. Ranieri, Andrew Webster, My P. T. Cao et al. · 2020 · Nature Communications
59. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy.
    Christian G. Daughton · 2002 · Environmental Health Perspectives
60. Virtual Screening Using Protein−Ligand Docking: Avoiding Artificial Enrichment
    Marcel L. Verdonk, Valério Berdini, Michael J. Hartshorn, Wijnand T. M. Mooij, Christopher W. Murray, Richard D. Taylor, Paul Watson · 2004 · Journal of Chemical Information and Computer Sciences
61. In silico ADME/T modelling for rational drug design
    Yulan Wang, Jing Xing, Yuan Xu, Nannan Zhou, Jianlong Peng, Zhaoping Xiong, Xian Liu, Xiaomin Luo, Cheng Luo, Kaixian Chen et al. · 2015 · Quarterly Reviews of Biophysics
62. The potential of alkaloids in drug discovery
    Geoffrey A. Cordell, Mary Lou Quinn‐Beattie, Norman R. Farnsworth · 2001 · Phytotherapy Research
63. Plant natural products: Back to the future or into extinction?
    James Dewey McChesney, Sylesh K. Venkataraman, John T. Henri · 2007 · Phytochemistry
64. Dendrimers: Novel Polymeric Nanoarchitectures for Solubility Enhancement
    Umesh Dutta Gupta, Hrushikesh Bharat Agashe, Abhay Asthana, Narendra Kumar Jain · 2006 · Biomacromolecules
65. Analysis of the Physicochemical Properties of Acaricides Based on Lipinski's Rule of Five
    Xiaoxia Chen, Hao Li, Lichao Tian, Qinwei Li, Jinxiang Luo, Yongqiang Zhang · 2020 · Journal of Computational Biology
66. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates
    Jeffrey A. Kramer, John E. Sagartz, Dale L. Morris · 2007 · Nature Reviews Drug Discovery
67. In Vivo Structure−Activity Relationship Study of Dorsomorphin Analogues Identifies Selective VEGF and BMP Inhibitors
    Jijun Hao, Joshua N. Ho, Jana A. Lewis, Kaleh Karim, R. Nathan Daniels, Patrick R. Gentry, Corey R. Hopkins, Craig W. Lindsley, Charles C. Hong · 2009 · ACS Chemical Biology
68. BCS class IV drugs: Highly notorious candidates for formulation development
    Rohan Ghadi, Neha Dand · 2017 · Journal of Controlled Release
69. Polysaccharide‐Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside
    Tianxin Miao, Junqing Wang, Yun Zeng, Gang Liu, Xiaoyuan Shawn Chen · 2018 · Advanced Science
70. One molecular fingerprint to rule them all: drugs, biomolecules, and the metabolome
    Alice Capecchi, Daniel Probst, Jean‐Louis Reymond · 2020 · Journal of Cheminformatics
71. Advances in De Novo Drug Design: From Conventional to Machine Learning Methods
    Varnavas D. Mouchlis, Antreas Afantitis, Angela Serra, Michele Fratello, Anastasios G. Papadiamantis, Vassilis Aidinis, Iseult Lynch, Dario Greco, Georgia Melagraki · 2021 · International Journal of Molecular Sciences
72. The pKaDistribution of Drugs: Application to Drug Discovery
    David T. Manallack · 2007 · Perspectives in Medicinal Chemistry
73. Molecular obesity, potency and other addictions in drug discovery
    Michael M. Hann · 2011 · MedChemComm
74. Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
    Quangang Zhu, Zhongjian Chen, Pijush Kumar Paul, Yi Lü, Wei Wu, Jianping Qi · 2021 · Acta Pharmaceutica Sinica B
75. Drug repurposing for antimicrobial discovery
    Maya A. Farha, Eric D. Brown · 2019 · Nature Microbiology
76. Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery
    S. Patching · 2017 · Molecular Neurobiology
77. QSAR Models Using a Large Diverse Set of Estrogens
    Leming M. Shi, Hong Fang, Weida Tong, Jie Wu, Roger Perkins, Robert M. Blair, William S. Branham, Stacy L. Dial, Carrie L. Moland, Daniel M. Sheehan · 2000 · Journal of Chemical Information and Computer Sciences
78. Absorption and Disposition of Ginsenosides after Oral Administration of Panax notoginseng Extract to Rats
    Houfu Liu, Junling Yang, Feifei Du, Xiumei Gao, Xutao Ma, Yühong Huang, Fang Xu, Wei Niu, Fengqing Wang, Yu Mao et al. · 2009 · Drug Metabolism and Disposition
79. Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis
    Sarfaraz K. Niazi, Zamara Mariam · 2023 · Pharmaceuticals
80. Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
    Donovan, Katherine A., Ferguson, Fleur M., Bushman, Jonathan W., Eleuteri, Nicholas A., Bhunia, Debabrata, Ryu, SeongShick, Tan, Li, Shi, Kun, Yue, Hong, Liu, Xiaoxi et al. · 2020 · Cell
81. Expression and function of efflux drug transporters in the intestine
    Mikihisa Takano, Ryoko Yumoto, Teruo Murakami · 2005 · Pharmacology & Therapeutics
82. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead
    Tambuyzer, Erik, Vandendriessche, Benjamin, Austin, Christopher P., Brooks, Philip J., Larsson, Kristina, Miller Needleman, Katherine I., Valentine, James, Davies, Kay, Groft, Stephen C., Preti, Robert et al. · 2020 · Nature Reviews Drug Discovery
83. Five computational developability guidelines for therapeutic antibody profiling
    Raybould, Matthew I. J., Marks, Claire, Krawczyk, Konrad, Taddese, Bruck, Nowak, Jaroslaw, Lewis, Alan P., Bujotzek, Alexander, Shi, Jiye, Deane, Charlotte M. · 2019 · Proceedings of the National Academy of Sciences
84. Chloride extrusion enhancers as novel therapeutics for neurological diseases
    Martin Gagnon, Marc J. Bergeron, Guillaume Lavertu, Annie Castonguay, Sasmita Tripathy, Robert P. Bonin, Jimena Pérez-Sánchez, Dominic Boudreau, Bin Wang, Lionel Dumas et al. · 2013 · Nature Medicine
85. A High-Throughput Screen for Aggregation-Based Inhibition in a Large Compound Library
    Brian Y. Feng, Anton M. Simeonov, Ajit Jadhav, Kerim Babaoglu, James Inglese, Brian K. Shoichet, Christopher P. Austin · 2007 · Journal of Medicinal Chemistry
86. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical Applications
    Johannes Kornhuber, Philipp Tripal, Martin Reichel, Christiane Mühle, Cosima Rhein, Markus Muehlbacher, Teja Wolfgang Groemer, Erich Gulbins · 2010 · Cellular Physiology and Biochemistry
87. Improving Oral Bioavailability of Peptides by Multiple N‐Methylation: Somatostatin Analogues
    Biron, Eric, Chatterjee, Jayanta, Ovadia, Oded, Langenegger, Daniel, Brueggen, Joseph, Hoyer, Daniel, Schmid, Herbert A., Jelinek, Raz, Gilon, Chaim, Hoffman, Amnon et al. · 2008 · Angewandte Chemie International Edition
88. Drug Targeting to the Brain
    Albertus Gerrit de Boer, Pieter Jaap Gaillard · 2006 · The Annual Review of Pharmacology and Toxicology
89. The p K BHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists
    Christian Laurence, Ken A. Brameld, Jérôme Graton, Jean‐Yves Le Questel, Éric Renault · 2009 · Journal of Medicinal Chemistry
90. In silico research in drug discovery
    Georg C. Terstappen, Angelo M. Reggiani · 2001 · Trends in Pharmacological Sciences
91. Macrocycles in Drug Discovery─Learning from the Past for the Future
    Diego García Jiménez, Vasanthanathan Poongavanam, Jan O. Kihlberg · 2023 · Journal of Medicinal Chemistry
92. Comparison of Deep Learning With Multiple Machine Learning Methods and Metrics Using Diverse Drug Discovery Data Sets
    Alexandru V. Korotcov, Valery Tkachenko, Daniel P. Russo, Sean Ekins · 2017 · Molecular Pharmaceutics
93. Drug research: myths, hype and reality
    Kubinyi, Hugo · 2003 · Nature Reviews Drug Discovery
94. Peptide therapeutics: Targeting the undruggable space
    Natia Tsomaia · 2015 · European Journal of Medicinal Chemistry
95. Prediction of intestinal permeability
    William J. Egan, Georgio Lauri · 2002 · Advanced Drug Delivery Reviews
96. Diversity-oriented synthesis; a challenge for synthetic chemistsElectronic supplementary information (ESI) available: Excel file of all the FDA new molecular entities between the years 1998 and July 2003, and new drug approvals between the years 1990 and 2002. See http://www.rsc.org/suppdata/ob/b3/b310752n/
    David R. Spring · 2003 · Organic & Biomolecular Chemistry
97. Quantitative analysis of drug delivery to the brain via nasal route
    Luba Kozlovskaya, Mohammed Abou-Kaoud, David Stepensky · 2014 · Journal of Controlled Release
98. Cyclodextrin-based nanosponges: A critical review
    Atul P. Sherje, Bhushan R. Dravyakar, Darshana Kadam, Mrunal Jadhav · 2017 · Carbohydrate Polymers
99. Chemical space as a source for new drugs
    Jean‐Louis Reymond, Ruud van Deursen, Lorenz C. Blum, Lars Ruddigkeit · 2010 · MedChemComm
100. How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets
     B.C. Doak, Jie Zheng, Doreen Dobritzsch, Jan O. Kihlberg · 2015 · Journal of Medicinal Chemistry